The combination that most reliably improves elderly medication adherence is a structured medication review, simplified dosing, caregiver involvement and targeted reminders, applied according to the cause of the problem. Forgetfulness responds best to reminders and routine, while frailty or dementia usually need a person-centred medication review and deprescribing first. A 2026 systematic review found multicomponent approaches raised adherence by 25 to 59% across pooled trials, and the Wigan Council case study shows how a digital system like YOURmeds can support that plan once the clinical groundwork is in place.
TL;DR:
- Multicomponent interventions, including medication review, simplification, reminders, and caregiver support, can improve adherence by up to 59%, especially when combined.
- Digital reminders alone have a modest impact, with SMS reminders roughly doubling adherence odds, but they are less effective for intentional non-adherence reasons.
- Addressing unintentional non-adherence requires tools tailored to memory or physical barriers, while intentional non-adherence often needs motivational conversations and trust-building.
- Structured medication reviews prioritize patients on multiple medicines or high-risk drugs and should be requested by caregivers if not offered routinely.
- Practical caregiver actions, like centralizing medicines, aligning doses with routines, and preparing questions for healthcare providers, can significantly improve medication adherence within a week.
Table of Contents
- How common is poor adherence, and what does the evidence show?
- Why do older people miss doses in the first place?
- Which interventions have real evidence behind them?
- What can caregivers do this week to help?
- What does a structured medication review actually involve?
- How do you choose a digital adherence tool that actually helps?
- How should you monitor adherence and know when to get help?
- Three steps to take in the next seven days
- What role do beliefs and mood play in taking medicine?
- How can better communication build trust around medication?
- Why does health literacy matter for taking medicines correctly?
- A more honest view of what adherence support should look like
- YOURmeds: a practical fit alongside structured review
- Sources
- FAQ
How common is poor adherence, and what does the evidence show?
A substantial proportion of medicines prescribed for long-term conditions are not taken as recommended, with older adults and people receiving social care particularly affected. The figure hides wide variation: a 2026 systematic review and meta-analysis found adherence ranging from 25.3% among institutionalised patients to 97.6% in high-support, pharmacist-led programmes. That gap says less about age than about the support structure around the person.
The same review pooled ten randomised trials of combined interventions, that is, caregiver support, digital platforms and regimen simplification used together, and found an average effect size of SMD 0.71 (95% CI: 0.11 to 1.54), translating to adherence gains of 25 to 59%. The confidence interval is wide and the heterogeneity across trials was high, meaning the studies measured adherence differently and tested different combinations of support. Read the finding as a strong signal that multicomponent care beats single-strand fixes, not as a promise of a precise result for any individual.
Combined interventions can lift adherence by up to 59% in pooled trials. A 2026 meta-analysis of ten randomised trials found this effect for approaches that paired caregiver support with simplification and digital reminders, though the certainty of evidence varies by outcome measured.
A broader umbrella review of interventions implementable in routine care reached a similar conclusion from a different angle: digital reminders improved adherence in around 59% of the cases reviewed, and pharmacist-delivered interventions produced larger measurable effects than approaches without pharmacist input. SMS reminders alone carried an odds ratio of roughly 2.11 for improved adherence, a meaningful but modest lift compared with structured, multi-strand programmes. None of this evidence claims a fix works for everyone: it points to a hierarchy where clinical review and simplification tend to matter more than the reminder technology layered on top.
Why do older people miss doses in the first place?
Non-adherence splits into two broad types, and telling them apart matters because the fixes are different. Unintentional non-adherence happens when someone wants to take their medicine correctly but cannot, usually because of memory, dexterity or a confusing schedule. Intentional non-adherence happens when someone decides, consciously or not, to skip a dose because of side effects, cost or doubts about whether the medicine is doing anything.
Several factors tend to compound at once in older patients:
- Cognitive impairment makes it hard to remember whether a dose was taken, not just to remember to take it.
- Polypharmacy and regimen complexity multiply the chances of error when several prescribers manage overlapping conditions.
- Physical limitations, including poor dexterity, low vision or swallowing difficulties, can make packaging and tablets themselves the barrier.
- Cost, transport and fragmented records create system-level friction that has nothing to do with willingness to take medicine.
- Formulation problems, such as large tablets or complicated blister packs, discourage consistent use even when motivation is high.
Pro Tip: Before choosing any tool or intervention, ask whether the missed doses are about remembering, physically managing the medicine, or deciding not to take it. Each answer points to a different fix.
A short checklist helps here: does the person forget doses, struggle to open packaging, run out before a repeat prescription arrives, or express doubts about a specific medicine? The answer usually points straight to the right intervention.
Which interventions have real evidence behind them?
Not every fix suits every problem, and stacking the wrong tool onto the wrong barrier wastes effort. The evidence points to four broad approaches, roughly in order of impact.
- Structured medication reviews (SMRs) and pharmacist-led review. Specialist Pharmacy Service guidance describes a seven-step, person-centred SMR process that prioritises patients with polypharmacy, frailty or high-risk medicines. The umbrella review found pharmacist-delivered interventions consistently outperformed non-pharmacist approaches, making this the first port of call when non-adherence is linked to complexity or uncertainty about why a medicine is prescribed.
- Regimen simplification and deprescribing. Reviews that clarify purpose and cut unnecessary medicines are consistently linked to better adherence in older adults. This has to happen under clinical supervision: stopping or combining medicines without a documented plan risks withdrawal effects or the return of symptoms the medicine was controlling.
- Caregiver education and motivational approaches. Where non-adherence is intentional, SPS guidance points to motivational interviewing and shared decision-making rather than more reminders. A caregiver who understands why someone is reluctant to take a statin or an antidepressant is better placed to have that conversation than any device.
- Digital reminders and dispensing devices. These work best for unintentional non-adherence. SMS reminders alone carry an odds ratio near 2.11 for improved adherence, and dispensing devices that combine visual prompts with alerts to a caregiver add a monitoring layer that plain reminders lack. Accessibility still matters: large text, few steps and no dependence on constant internet access make the difference between a tool that gets used and one that gets abandoned.
The strongest pattern across the evidence is that no single component does the job alone. The 2026 meta-analysis found multicomponent interventions, review plus simplification plus caregiver support plus reminders, outperformed any single strand tested in isolation.
What can caregivers do this week to help?
Small, practical changes often move the needle before any clinical review happens. Start with the physical environment:
- Centralise medicines in one place, check formulations against the current prescription list, and discard anything past its expiry date.
- Align doses with daily routines, such as taking morning tablets with breakfast, and ask a pharmacist whether timings can be consolidated safely.
- Match reminders to the cause: alarms and pill organisers for forgetfulness, larger print or easy-open packaging for dexterity problems.
- Prepare for an SMR appointment by bringing every medicine, including over-the-counter products and supplements, plus a note of any missed or doubled doses.
- Store medicines securely and avoid stockpiling old prescriptions, which increases confusion and the risk of taking an outdated dose.
Pro Tip: Write down two or three specific questions before a pharmacy or GP appointment, such as “which of these could we stop?” or “why was this dose increased?” A focused question gets a more useful answer than a general one.
Caregivers do not always realise they can request a structured medication review directly rather than waiting for one to be offered, and doing so can speed up simplification considerably.
What does a structured medication review actually involve?
An SMR follows a seven-step pattern described in Specialist Pharmacy Service guidance: gather the full medication history, assess how each medicine is working, agree goals with the patient, identify anything that may be causing more harm than benefit, personalise the plan to the individual, agree specific actions, then implement and monitor the changes.
Certain patients are prioritised for review: those on ten or more regular medicines, people living with frailty, and anyone taking high-risk medicines such as anticoagulants or opioids. Frailty-specific guidance recommends the same structured approach with closer monitoring during any change.
Deprescribing within an SMR follows three principles:
- Change one medicine at a time so any effect, good or bad, can be attributed correctly.
- Document the plan and the reasoning, including what to watch for.
- Monitor for withdrawal symptoms or the return of the original condition, with a clear point of contact if something changes.
Community pharmacy and carers both have a role in the follow-up stage, since they are often the first to notice a symptom returning or a new side-effect appearing.
How do you choose a digital adherence tool that actually helps?
The right tool depends on the problem, not on which device looks most advanced. Alarms and simple reminders suit people who forget occasional doses but manage the physical act of taking medicine without difficulty. Dispensing devices with visual prompts suit people juggling several medicines a day, where the challenge is sequencing rather than memory alone. Remote monitoring features matter most for caregivers who live at a distance and need to know a dose was taken without a phone call.
A short accessibility checklist helps narrow the field:
- Large, clear prompts that do not require reading small print or navigating menus.
- Minimal steps between the alert and taking the medicine.
- No dependence on constant WiFi, since connectivity gaps are common in older adults’ homes.
- Low ongoing maintenance, so refills and updates do not become a new burden.
Technology cannot fix intentional non-adherence on its own. Where someone has decided a medicine is not worth taking, a reminder just becomes an alert they learn to ignore; that situation calls for a conversation, not another alarm.
Wigan Council implemented a digital medication system of this kind as part of its social care support, illustrating how a device-based approach can sit alongside SMR-led care rather than replace it. Readers wanting the detail can read the Wigan Council case study for the specifics of that rollout.
How should you monitor adherence and know when to get help?
Monitoring does not need to be complicated. Simple options include checking whether repeat prescriptions are collected on schedule, keeping a basic dose log, running a quick weekly check-in, or reviewing reports from a dispensing device if one is in use.
Certain signs mean it is time to contact a GP or pharmacist rather than waiting:
- Recurrent missed doses despite reminders or a simplified schedule.
- New confusion, falls or unexplained symptoms, which can signal either a missed dose or a medicine no longer suiting the person.
- No improvement after two to three weeks of trying a new reminder or routine.
- Any sign of doubling up on doses, which is a safety issue rather than a preference to manage informally.
Whatever changes, share the update with every prescriber and carer involved, not just the person who noticed it. Fragmented records are one of the barriers this entire approach is trying to solve.
Three steps to take in the next seven days
Start with the basics rather than the technology. First, centralise every medicine in one place and check it against the current prescription list. Second, if there is any sign of polypharmacy, confusion about purpose, or a high-risk medicine involved, request a structured medication review rather than waiting for one to be offered. Third, set a simple reminder matched to the actual cause of missed doses, whether that is an alarm, a pill organiser or a family check-in call.
Give this combination a week before judging it. Improvement in an SMR-led plan can take longer to show, since dose changes need monitoring, but a reminder aimed at forgetfulness should show a difference almost immediately. Keep a short note of what changed and share it at the next appointment.
What role do beliefs and mood play in taking medicine?
Adherence is not purely mechanical. Someone who doubts a medicine is working, worries about side-effects, or feels it confirms they are “sick” may quietly stop taking it, regardless of how good the reminder system is. Depression is a particularly important factor: low motivation and a sense that nothing will help can undermine even a well-organised routine, and it often goes unnoticed because the person still seems to be managing.
These psychological barriers explain why SPS guidance recommends shifting from a “compliance” mindset, where the patient simply follows instructions, to a genuine partnership that explores the reasons behind non-adherence before choosing a tool. A caregiver who notices withdrawal, low mood or repeated scepticism about a specific medicine should raise it with a GP rather than assuming a stronger reminder will solve it. The fix here is conversation and, where needed, treatment for the underlying mood or belief, not a louder alarm.
How can better communication build trust around medication?
Trust between an older adult and their prescriber tends to break down for a specific reason: the person does not understand why a medicine was started, changed or stopped. Clear, plain-language explanations at the point of prescribing reduce that uncertainty considerably. Asking open questions, such as “what worries you about this tablet?” rather than “are you taking this correctly?”, tends to surface the real barrier faster.
Caregivers can support this by attending appointments when welcomed, keeping a written list of concerns beforehand, and asking the prescriber to explain any change in plain terms rather than accepting a brand or dose change without context. Continuity also matters: seeing the same GP or pharmacist over time builds the kind of trust that makes someone more likely to mention a missed dose rather than hide it. Where trust is already strained, a structured medication review offers a natural reset point, since it is built around the patient’s own goals rather than a checklist of instructions.
Why does health literacy matter for taking medicines correctly?
Understanding what a medicine does, why the timing matters and what happens if a dose is missed all depend on health literacy, and this varies widely among older adults regardless of general education level. Complex medical language on labels or discharge letters can leave someone technically informed but practically unclear about what to actually do.
Education interventions that work tend to share a few features: they use plain language, they check understanding rather than assuming it, and they are delivered more than once rather than as a single leaflet handed over at discharge. A pharmacist explaining a new regimen face-to-face, with the chance to ask questions, tends to achieve more than written instructions alone. For caregivers, the practical takeaway is to ask the prescribing team to explain the purpose of each medicine in plain terms and to repeat that explanation whenever a new medicine is added, rather than assuming earlier explanations still hold.
A more honest view of what adherence support should look like
Adherence is not something you achieve by enforcing a schedule. It is a negotiation between what a person wants for their health, what a medicine can realistically do, and how much daily effort they are willing to give it. Treating a missed dose as a discipline problem misses the point most of the time.
Digital tools help with memory and monitoring, but they cannot replace a review that questions whether a medicine is still needed at all, and deprescribing should never happen without clinical oversight. The most useful thing a caregiver can do is keep asking why, then bring that question to a pharmacist.
— Josh
YOURmeds: a practical fit alongside structured review
Once a medication review has simplified a regimen, YOURmeds gives caregivers a way to keep it working day to day. The system uses smart blister packs with beeping alarms and numbered visual prompts, described by the company as being as simple to follow as matching a bingo number, alongside a companion app that gives family or care staff real-time visibility of missed or incorrect doses. Packs can be filled at home or by a pharmacy, and the device is designed to function without constant WiFi.
This suits families managing a relative’s medicines remotely, and social care organisations supporting several people at once. Wigan Council’s implementation, detailed in the case study, shows how the approach worked in a council care setting. To see current subscription and monitoring options, visit YOURmeds or explore the YOURmeds Switch pack for family monitoring features.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
What is the biggest cause of poor medication adherence in older adults?
There is no single cause: unintentional factors like memory and dexterity, and intentional factors like doubts about side-effects, both play a major role. NICE recommends identifying which type applies before choosing a fix, since reminders help one and not the other.
Can digital reminders alone fix missed doses?
Digital reminders help mainly with unintentional non-adherence, such as forgetting a dose. An umbrella review found SMS reminders carried an odds ratio of around 2.11 for improved adherence, but reminders alone rarely help when someone has deliberately decided not to take a medicine.
What is a structured medication review and who should ask for one?
A structured medication review (SMR) is a seven-step, person-centred process that checks whether each medicine is still needed and working as intended, described in Specialist Pharmacy Service guidance. It is prioritised for people on many regular medicines, those living with frailty, or anyone taking a high-risk medicine, and caregivers can request one rather than waiting for it to be offered.
How much can combining interventions improve adherence?
A 2026 meta-analysis of ten randomised trials found that combining caregiver support, digital reminders and regimen simplification improved adherence by 25 to 59%, outperforming any single approach used alone. The certainty of this estimate is moderate, since the trials varied in design and measurement.
Does a device like YOURmeds replace the need for a medication review?
No, a dispensing and reminder system like YOURmeds is designed to support a regimen after it has been reviewed and simplified, not to replace clinical decisions about which medicines are needed. It gives caregivers real-time visibility of missed or incorrect doses, which works best alongside, not instead of, a structured medication review.
